drugset
drugset / Trial / NCT05440643

Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

NCT05440643 ↗

Phase 1/2 Completed 209 enrolled ALK-Abelló A/S Parexel · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical research study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with peanut allergy.

Timeline

Start
2022-09-07
Primary completion
2026-03-10
Completion
2026-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Peanut extract Unknown — Other

Indications

food allergy